news
News
Incentivising the development of new...

Incentivising the development of new antibacterial treatments: Progress report by the Global AMR R&D Hub and WHO 2023

In 2021 and 2022, G7 Finance and Health Ministers committed to expedite implementation of existing antimicrobial resistance (AMR) strategies, to take additional steps to address antibiotic market failure, create economic conditions to preserve the effectiveness of essential existing antibiotics and ensure their access, strengthen AMR research and development (R&D), and bring novel antibacterials to market that address public health needs. An initial progress report was prepared by the Global AMR R&D Hub and WHO for the G7 Finance and Health Ministers in May 2022, with a progress update requested for 2023.

Curious about more?

You can sign up for our newsletter here. By subscribing, you automatically provide your consent for the use of your data in accordance with our privacy policy.

This field is for validation purposes and should be left unchanged.

Latest news

Go to all news
18.10.2024

Hub-WHO Joint G7 Progress Report Published

The Hub and WHO have published their annual progress report on activities G7 countries are undertaking to incentivise the development of new antibacterials.
Read more
Newsletter
01.10.2024

Global AMR R&D Hub Newsletter – September 2024

Our September 2024 Newsletter is out! Catch up on our recent news, including  welcoming South Africa as our new Board member, and reflections following the much anticipated UNGA High-Level Meeting on AMR - a pivotal moment for collective actions against AMR! We are deeply grateful to Andre Abreu from the Ministry of Health in Brazil for this edition's editorial.
Read more
News
30.09.2024

Reflecting on a pivotal moment: UN High-Level Meeting on AMR

The UN General Assembly High-Level Meeting on Antimicrobial Resistance (AMR) took place on September 26th, at UNGA 79 in New York, marking only the second time world leaders have united at this level to confront the global threat of drug-resistant infections.
Read more
News
22.09.2024

Sustainable Access to Effective Antibiotics: The Path from UNGA to IMPACT

To elevate the conversation around Antimicrobial Resistance (AMR) and push for action and political commitment, the One Health Trust, in collaboration with Africa CDC, US Centers for Disease Control and Prevention, IFPMA, FIND, AMR Action Fund, The International Centre for Antimicrobial Resistance Solutions (ICARS), IDSA, Bill & Melinda Gates Foundation, and the Global AMR R&D Hub, hosted a side event just ahead of the UNGA High-Level Meeting on AMR.
Read more
Dynamic Dashboard